|
|
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vol. 13, Issue 10, 3431-3440, October 2002
B Involves
Selective Degradation of Plasma Membrane-associated I
B
and
*Department of Experimental Radiation Oncology, The University of
Texas M. D. Anderson Cancer Center, Houston, Texas 77030; and
Molecular Radiation Therapeutics Branch, Radiation
Oncology Science Program, National Cancer Institute, Bethesda, Maryland
20892
| |
ABSTRACT |
|---|
|
|
|---|
In contrast to nuclear factor-
B (NF-
B) activation by tumor
necrosis factor-
(TNF-
), the specific processes involved in the
activation of this transcription factor by ionizing radiation (IR) have
not been completely defined. According to the classical paradigm, a
critical event in NF-
B activation is the degradation of I
B
.
Data presented herein show that, in contrast to treatment with TNF-
,
IR-induced NF-
B activation was not accompanied by degradation of
I
B
in the U251 glioblastoma cell line as determined in whole cell
lysates. However, treatment with the proteosome inhibitor MG-132
inhibited NF-
B activation induced by IR, suggesting that I
B
degradation was a critical event in this process. To reconcile these
results, U251 cell lysates were separated into soluble and insoluble
fractions and I
B
levels evaluated. Although I
B
was found in
both subcellular fractions, treatment with IR resulted in the
degradation of I
B
only in the insoluble fraction. Further
subcellular fractionation suggested that the IR-sensitive, insoluble
pool of I
B
was associated with the plasma membrane. These data
suggest that the subcellular location of I
B
is a critical
determinant in IR-induced NF-
B activation.
| |
INTRODUCTION |
|---|
|
|
|---|
The transcription factor nuclear factor-
B (NF-
B) is
susceptible to activation by a variety of stimuli and conditions
(Anderson et al., 1994
; Koong et al., 1994
; Li
and Karin, 1998
; Uehara et al., 1999
; Gao et al.,
2001
). Initially, NF-
B was shown to play a major role in the
regulation of genes involved in inflammation and immunity (Siebenlist
et al., 1994
; Pomerantz and Baltimore, 1999
) with more
recent data indicating that it can also serve as a survival factor
protecting cells from undergoing apoptosis in response to stress or
toxic insult (Zhang et al., 2000
; Bottero et al.,
2001a
). Given its significance in a number of critical biological
processes, there is considerable impetus to define the factors and
signaling pathways that regulate NF-
B activation. The biochemical
events involved in the activation of NF-
B have been for the most
part delineated using cytokines, primarily tumor necrosis factor-
(TNF-
). According to the classical paradigm, NF-
B is sequestered
as an inactive complex in the cytoplasm by its inhibitor, I
B
(Siebenlist et al., 1994
). Exposure to TNF-
or other
stimuli results in the activation of I
B kinase (IKK) (Nasuhara
et al., 1999
), which phosphorylates I
B
on two specific serine residues (Schottelius et al., 1999
). The
phosphorylated form of I
B
is then ubiquinated and degraded,
unmasking the nuclear localization sequence on NF-
B and
allowing it to be imported into the nucleus (Duffey et al.,
1999
).
Among the agents capable of activating NF-
B is ionizing radiation
(IR). However, although there have been a number of reports of
IR-induced NF-
B activation in a variety of cell types, there are
suggestions that the processes involved differ from those defined for
TNF-
. IR induces the activation of NF-
B beginning 2-4 h after
exposure with its activity returning to untreated levels by ~8 h
(Brach et al., 1991
; Mohan and Meltz, 1994
; Russell et
al., 2002
). This is in contrast to TNF-
-mediated activation of
NF-
B, which occurs with peak activation at 30 min (Claudio et
al., 1996
; Raju et al., 1997
; Russell et
al., 2002
). These disparate time courses suggest that there are
fundamental differences in the TNF-
- and IR-initiated signaling
pathways leading to NF-
B activation. Furthermore, activation of
NF-
B by IR was shown to occur in the absence of I
B
degradation
in rat astrocytes and the human glioma cell line U373 (Raju et
al., 1998
). In addition to experimental observations comparing
TNF-
and IR, the obvious differences between the agents themselves
(i.e., cytokine vs. physical deposition of energy) suggest the
involvement of unique signaling pathways mediating the activation of
NF-
B.
In an attempt to define the specific processes involved in IR-induced
NF-
B activation, we have evaluated the events previously shown to
mediate NF-
B activation after TNF-
treatment. Initial observations indicated that, in contrast to treatment with TNF-
, IR-induced activation of NF-
B in U251 cells was not associated with
the degradation of I
B
. However, upon further investigation, the
data presented herein show that I
B
degradation is required for
IR-induced NF-
B activation and can be detected when the insoluble cell fraction is evaluated. Furthermore, the I
B
located in the plasma membrane seems to be selectively targeted by IR, whereas TNF-
degrades I
B
located in each of the cell fractions examined. Thus,
data presented herein suggest that subcellular localization of the
I
B
/NF-
B complex can be a determining factor in the
susceptibility of NF-
B to IR-induced activation.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Antibodies and Reagents
Antibodies to nucleoporin, calnexin, BiP, GM130, and VLA-2
were obtained from BD PharMingen (San Diego, CA). Cytochrome
c oxidase I antibody was from Molecular Probes (Eugene, OR).
Antibodies to I
B
, I
B
, I
B
, NF-
B p65, epidermal
growth factor receptor (EGFR), and hexokinase IV were acquired from
Santa Cruz Biotechnology (Santa Cruz, CA). Dimethyl sulfoxide and human
TNF-
were purchased from Sigma-Aldrich (St. Louis, MO). Actin
antibody was purchased from Chemicon International (Temecula, CA).
MG-132 was purchased from BIOMOL Research Laboratories (Plymouth
Meeting, PA).
Cell Lines and Culture Conditions
The human glioblastoma cell lines U251 and SF539 and the
pancreatic BXPC-3 cell line were obtained from American Type Culture Collection (Manassas, VA) and maintained as described previously (Russell et al., 2002
).
Radiation
Cultured monolayer cells were irradiated using a 137Cs source at a dose rate of 3.7 Gy/min (U.S. Nuclear, Burbank, CA).
Electrophoretic Mobility Shift Assay (EMSA)
The preparation of nuclear extracts and EMSA analysis were
described previously (Russell et al., 2002
).
Separation into Insoluble and Soluble Cell Fractions
Cellular fractionation was performed as described previously
(Bergo et al., 2000
) with several modifications. Briefly,
cell cultures (8 × 106 cells) were washed
twice with phosphate-buffered saline (PBS), scraped into 10 ml of PBS,
and pelleted at 500 × g. The supernatant was
aspirated, and the cell pellet was resuspended in three volumes of
hypotonic lysis buffer (10 mM Tris, pH 7.4, 0.1 M sucrose, 10 mM NaCl,
1 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride, 1 mg/ml
aprotinin, 1 mg/ml leupeptin, 250 mg/ml benzamide). The suspension was
incubated on ice for 10 min, subjected to three rounds of
freezing/thawing, and vortexed for 30 s to ensure complete cell
breakage. Samples were spun at 100,000 × g for 60 min
at 4°C. The supernatant (S100) was treated with 1% NP-40 and
collected as the soluble fraction and stored at
80°C. The pellet
(P100) was resuspended in hypotonic lysis buffer with 1% NP-40,
incubated on ice for 30 min, and vortexed for 30 s at 10-min
intervals. The insoluble fraction was then stored at
80°C. Protein
concentrations were determined using the DC protein assay kit (Bio-Rad,
Hercules, CA).
Subcellular Fractionation
Subcellular fractionation was performed as described previously
(Nantel et al., 1999
) with several modifications. Briefly, cell cultures (40 × 106 cells) were washed
twice with PBS, scraped into 10 ml of PBS, and pelleted at 500 × g. The supernatant was aspirated, and the cell pellet was
resuspended in three volumes of hypotonic lysis buffer (see above). The
suspension was incubated on ice for 10 min and run three times through
a 22-gauge needle to ensure complete cell breakage. Samples were then
spun at 500 × g for 5 min at 4°C. The supernatant
was removed and held for additional processing. The initial pellet was
resuspended in 2 volumes of hypotonic lysis buffer, incubated on ice
for 10 min, and spun again at 500 × g for 5 min at
4°C. The washing of the pellet was repeated twice, each time
combining the extracted supernatants. Finally, the low-speed pellet
(P1) was resuspended in 3 volumes of extraction buffer (20 mM HEPES, pH
7.9, 400 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% NP-40, 1 mM dithiothreitol,
1 mM phenylmethylsulfonyl fluoride, 1 mg/ml aprotinin, 1 mg/ml
leupeptin, 250 mg/ml benzamide) and incubated on ice for 30 min while
vortexing for 30 s at 10-min intervals. The combined supernatants
were spun at 500 × g for 5 min at 4°C to remove any
unbroken cells, remaining nuclei, or other large debris. The
supernatant was then transferred to a new Eppendorf tube and spun at
18,000 × g for 30 min at 4°C. The resulting pellet (P2) was resuspended in two volumes of extraction buffer and incubated on ice for 30 min while vortexing for 30 s at 10-min intervals. The remaining supernatant was then spun at 100,000 × g
for 60 min at 4°C. The resulting high-speed pellet (P3) was
resuspended in one volume of extraction buffer and incubated on ice for
30 min while vortexing for 30 s at 10-min intervals. The
supernatant (S100) was collected as the S fraction, treated with 1%
NP-40, and incubated on ice for 30 min while vortexing for 30 s at
10-min intervals. Cellular fractions were then stored at
80°C and
protein concentrations were subsequently determined using the DC
protein assay kit (Bio-Rad).
Sucrose Density Gradients
The P2 pellets were collected as described above and subjected
to sucrose density gradient centrifugation as described in Hubbard
et al. (1983)
and Meier et al. (1984)
with
several modifications. Sucrose density gradients were generated by
layering three concentrations of sucrose (1.5, 0.75, and 0.375 M;
chilled to 4°C) in 3-ml volumes in an ultracentrifuge tube. Samples
(P2 pellets) were resuspended in 1 ml of 0.375 M sucrose and added to
the top layer. The gradients were then spun at 100,000 × g for 4 h at 4°C. Tubes were then removed and kept on
ice. The interface between sucrose layers was collected by inserting an
18-gauge needle into the interface and removing a volume of 1.5 ml. The
interface between the 1.5 and 0.75 M sucrose was collected as the lower
interface and the interface between the 0.75 and 0.375 M sucrose was
collected as the upper interface. The extracted volumes were then
resuspended to 3 ml 0.375 sucrose and spun at 100,000 × g for 1 h at 4°C. The supernatant was aspirated and
the pellet was resuspended in 1 volume of extraction buffer. Sucrose
gradient cell fractions were then stored at
80°C. Protein
concentrations were subsequently determined using the DC protein assay
kit (Bio-Rad).
Plasma Membrane Isolation
Isolation of a pure plasma membrane fraction is limited by
contamination with endoplasmic reticulum (ER) (Hubbard et
al., 1983
). Lin et al. (1988)
describe a method of
adding CaCl2 to cell lysates to reduce ER
contamination and enrich plasma membrane fractions. Direct isolation of
the plasma membrane (PM) was performed as described previously (Lin
et al., 1988
) with several modifications. Isolation of the
P2 pellet was performed as stated above; however, for these studies the
pellet was resuspended in 400 µl of hypotonic lysis buffer with
CaCl2 added to a final concentration of 10 mM. After incubation on ice for 10 min, the sample was gently vortexed and
diluted to 1 ml with 0.375 M sucrose. The
CaCl2-treated sample was then subjected to a
sucrose density gradient as described above. The lower interface was
then isolated, spun down at 100,000 × g for 1 h
at 4°C, and resuspended in 1 volume of extraction buffer. The PM
fraction was then stored at
80°C. Protein concentrations were
subsequently determined using the DC protein assay kit (Bio-Rad).
Endoplasmic Reticulum Isolation
Isolation of the ER was achieved as follows. Briefly, cell
cultures (40 × 106 cells) were washed twice
with PBS, scraped into 10 ml of PBS, and pelleted at 500 × g. The supernatant was aspirated and the cell pellet was
resuspended in 3 volumes of hypotonic lysis buffer (see above). The
suspension was incubated on ice for 10 min and run three times through
a 22-gauge needle to ensure complete cell breakage. Samples were then
spun at 500 × g for 5 min at 4°C. The initial
supernatant was removed and discarded. The remaining nuclear pellet was
resuspended in 2 volumes of hypotonic lysis buffer and spun at 500 × g for 5 min at 4°C. The washing of the pellet was
repeated three times. The nuclear washes were then combined and were
spun at 500 × g for 5 min at 4°C to remove any unbroken cells, remaining nuclei, or other large debris. The
supernatant was then diluted to a volume of 1 ml with 0.375 M sucrose.
The sample was then subjected to a sucrose density gradient as
described above. The lower interface was isolated, spun at 100,000 × g for 1 h at 4°C, and resuspended in 1 volume of
extraction buffer. The ER fraction was then stored at
80°C. Protein
concentrations were subsequently determined using the DC protein assay
kit (Bio-Rad).
Immunoblot Analysis
Immunoblot analysis was performed as described
previously (Russell et al., 2002
).
Confocal Microscopy
Confocal microscopy was performed as described previously (Pepin
et al., 1994
) with several modifications. Briefly, 1 × 105 cells were plated in four-well chamber slides
and allowed to grow for 48 h. Slides were then treated with either
radiation (10 Gy) or TNF-
(10 ng/ml). Immediately after treatment
the media were replaced with serum-free media containing the EGFR
antibody at a 1:50 dilution for 2 h. At the appropriate time point
(2 h after IR and 30 min after TNF), the slides were fixed in 4%
paraformaldehyde for 2 min and permeabilized for 3 min in a 1%
NP-40/PBS solution. Slides were then washed and allowed to incubate
with the I
B
antibody at a 1:50 dilution in 1% bovine serum
albumin in PBS for 2 h. After washing with PBS, the appropriate
secondary antibodies (fluorescein isothiocyanate and Texas Red
conjugates) were applied at a dilution of 1:100 in 1% bovine serum
albumin for 1 h. Slides were then washed, the chambers removed,
and antifade (DAKO, Carpinteria, CA) added to the slide. Coverslips
were then applied and sealed with nail polish. Slides were then
observed under a laser scanning 510 LSM confocal microscope (Carl
Zeiss, Thornwood, NY). Images were captured using LSM software package
(Carl Zeiss).
| |
RESULTS |
|---|
|
|
|---|
As an initial characterization of radiation-induced NF-
B
activation in the human glioma cell line U251, NF-
B/DNA binding was
determined as a function of time after exposure to 10 Gy. As shown in
Figure 1, there is a relatively low basal
level of NF-
B activity in U251 cells, which is increased by IR in a
time-dependent manner, reaching a maximum at 2 h and returning to
control levels by 8 h after exposure. This time course is in
contrast to U251 cells treated with TNF-
, in which case maximal
NF-
B activity was induced within 30 min (Russell et al.,
2002
).
|
According to the classical paradigm, a critical event in NF-
B
activation is the degradation of I
B
, which allows NF-
B to translocate to the nucleus (Karin and Ben Neriah, 2000
). Thus, as a
further comparison between TNF-
and IR-induced NF-
B activation, I
B
protein levels were determined in U251 whole cell lysates after each treatment. In U251 cells treated with TNF-
, I
B
levels were significantly reduced by 5 min and returned to control
levels by 60 min (Figure 2A), consistent
with previous reports (Claudio et al., 1996
). In contrast,
after exposure to IR, no significant degradation of I
B
was
detected (Figure 2B). In addition to I
B
, other I
B proteins
have been shown to play a role in the regulation of NF-
B activation
(Baeuerle and Baltimore, 1996
; Renard et al., 2000
). To
determine whether I
B
and I
B
were involved in IR-induced NF-
B in U251 cells, the levels of these two proteins were determined by immunoblot analysis. As shown in Figure
3A, TNF-
exposure resulted in the
degradation of I
B
with the same kinetics as I
B
, but did not
affect I
B
. Treatment with IR had no effect on levels of I
B
or I
B
(Figure 3B).
|
|
The above-mentioned results suggested that degradation of I
B
is
not necessary for radiation-induced NF-
B activation in U251 cells.
To test this hypothesis, U251 cells were treated with the proteosome
inhibitor MG-132. If I
B
degradation is not required for NF-
B
activation in U251 cells, MG-132 should not affect NF-
B DNA binding
after IR. However, as shown in Figure 4,
MG-132 significantly reduced radiation-induced NF-
B DNA binding
activity, indicating that degradation of I
B
is indeed an
essential step in IR-induced NF-
B activation.
|
Because I
B
exists primarily in the cytoplasm, its degradation
after exposure to activators of NF-
B is typically evaluated and
detected using whole cell lysates, as shown in Figure 2, A and B. However, I
B
has also been detected in other subcellular compartments (Suyang et al., 1996
; Hay et al.,
1999
; Rodriguez et al., 1999
; Sachdev et al.,
2000
). To determine whether radiation affects I
B
located at other
sites, U251 cell lysates were separated into soluble (S) and insoluble
(I) fractions (see MATERIALS AND METHODS) and I
B
levels
determined by immunoblot analysis. For these studies,
cytochrome c oxidase I, which is localized to the mitochondrial membrane, was used as a marker for the insoluble fraction
and hexokinase IV, which is found in the cytoplasm, was used as a
marker for the soluble fraction (Figure
5). In U251 cells the majority of
I
B
is present in the soluble fraction, with a significantly
smaller level found in the insoluble fraction. Whereas treatment of
U251 cells with TNF-
induced degradation of I
B
in both
fractions, exposure of cells to IR had no effect on I
B
levels in
the soluble fraction, which corresponds to the cytoplasm, but did
result in the loss of I
B
from the insoluble fraction. To examine
the effects of IR and TNF-
on the other isoforms of I
B,
additional immunoblot analysis was performed on the
insoluble and soluble fractions. Although I
B
was found in both
insoluble and soluble fractions, I
B
was only detected in the
soluble fraction. Whereas the soluble pool of I
B
was reduced
after TNF-
treatment, IR had no effect on I
B
or I
B
levels.
|
The effects of IR on I
B
located in the insoluble fraction were
then characterized as a function of time after irradiation and dose
(Figure 6). After 10 Gy a decrease in
I
B
levels in the insoluble fraction was detected by 1 h and
remained suppressed until 24 h post-IR. No significant change in
I
B
levels was detected in the soluble fraction at any of the time
points examined after IR. At 2 h after IR, doses as low as 5 Gy
resulted in loss of I
B
from the insoluble fraction, whereas doses
of up to 40 Gy had no significant effect on I
B
in the soluble
fraction. The loss of I
B
from the insoluble fraction is
consistent with IR-induced NF-
B activation in terms of dose and time
course. Furthermore, these data account for the failure to detect
I
B
degradation after IR when whole cell lysates are evaluated.
That is, the I
B
located in the soluble fraction (cytoplasm),
which is not affected by IR, masks the IR-induced loss of I
B
in
the insoluble fraction, which is present in considerably smaller
levels.
|
To determine whether the existence of IR-sensitive I
B
in the
insoluble fraction was unique to U251 cells, two additional cell lines
were evaluated. Previously, we showed that the SF539 glioma cell line
had a low basal level of NF-
B activity, which was significantly
increased after 10 Gy IR with the same kinetics as the U251 cell line
(Russell et al., 2002
). In contrast, the BXPC-3 pancreatic
cell line has a relatively high basal level of NF-
B activity that is
not enhanced by IR (Russell et al., 2002
). Evaluation of
immunoblots of whole cell lysates from SF539 and BXPC-3
cell line did not show any degradation of I
B
after 10 Gy IR (our
unpublished data). As shown in Figure
7A, when SF539 cell lysates were
separated into insoluble and soluble fractions, I
B
is detectable
in both fractions; IR induced the loss of I
B
only from the
insoluble fraction, whereas treatment with TNF-
resulted in
degradation of I
B
located in the insoluble and soluble fractions.
These results are similar to those for U251. In contrast, in the BXPC-3
cell line, I
B
was only detected in the soluble fraction, which
was reduced after TNF-
treatment but not after IR (Figure 7B). The
same markers (cytochrome c oxidase I and hexokinase IV) used
for U251 cells described above were used as a measure of the
effectiveness of the isolation procedure in these cell lines.
|
As a first step in determining the specific subcellular site(s) in
which the IR-sensitive I
B
is located, U251 cell lysates were
subjected to serial differential centrifugation (see MATERIALS AND
METHODS). Cell lysates were spun at specified rates, which resulted in
four fractions (P1, 500 × g pellet; P2, 18,000 × g pellet; P3, 100,000 × g pellet; S,
100,000 × g supernatant) and subjected to
immunoblot analysis. As shown in Figure
8A, I
B
was found in all three
pellets representative of the insoluble fraction (P1, P2, and P3), as
well as in the S fraction, which corresponds to the cytoplasm. Whereas
TNF-
degraded I
B
in all four fractions (Figure 8A), IR induced
the loss of I
B
only from the P2 fraction (Figure 8B). The lack of
effect of IR on the pool of I
B
localized to the S fraction as
well as the IR-induced degradation of I
B
in an insoluble fraction
(P2) was consistent with previous results in this study (Figure 5). To
define the organelles found in the P2 fraction, immunoblots
were probed with antibodies to specific protein markers corresponding
to the nucleus (nucleoporin), mitochondria (cytochrome c
oxidase I), plasma membrane (VLA-2
), ER (BiP), Golgi (GM130), and
cytoplasm (hexokinase IV). As shown in Figure 8C, the P2 pellet, which
contained the IR-sensitive I
B
, was composed of mitochondria,
plasma membrane, ER, and Golgi complex and was relatively free of
nuclei or cytoplasm. None of the organelle markers were affected by
treatment with IR.
|
To delineate the components of the P2 fraction isolated from U251
cells, the P2 pellet was added to a sucrose density gradient (SDG) and
subjected to high-speed centrifugation (see MATERIALS AND METHODS).
Immunoblot analyses of the SDG interfaces were then performed. As shown in Figure 9A,
I
B
and p65 NF-
B were both localized to the lower interface
fraction of the SDG. When the same procedure was performed on U251
cells exposed to 10 Gy 2 h previously there was a significant loss
of each protein, which is consistent with I
B
being degraded and
NF-
B translocating to the nucleus (Karin and Ben Neriah, 2000
). To
identify the subcellular components in the lower interface of the SDG,
the same marker proteins used in Figure 8C were analyzed. As shown in
Figure 9B, the lower interface of the SDG, which contained the
IR-sensitive I
B
, was enriched in plasma membrane and ER and
relatively free of mitochondria or Golgi complexes.
|
The results from Figure 9 suggest that the radiosensitive pool of
I
B
is associated with either the ER or PM. To separate ER from
the PM it was necessary to use individual isolation schema. For the PM
fraction, CaCl2-treated P2 pellets (Lin et
al., 1988
) were passed through the SDG. The lower interface of the
SDG was then isolated and subjected to immunoblot analyses.
Enriched ER fractions were obtained from combined washes of the
low-speed (nuclear) pellet followed by SDG separation. The lower
interface of the SDG was then isolated and subjected to
immunoblot analyses. For these studies EGFR and calnexin
were used as markers of the PM and ER, respectively. As shown in Figure
10A, enriched ER and PM fractions were
obtained as indicated by a decrease of EGFR in the ER fraction and an
increase in EGFR in the PM fraction. However, the greatest enrichment
was achieved for I
B
, which was only detected in the fraction
corresponding to the PM marker. These results suggest that I
B
is
preferentially associated with the plasma membrane and not the ER. As
shown in Figure 10B, in PM fractions isolated from irradiated U251
cells, there was a significant loss of both I
B
and p65 NF-
B.
Thus, these results further suggests that the IR-sensitive pool of
I
B
/NF-
B is located in the plasma membrane.
|
However, because of an inability to more completely reduce the ER
component in the PM fraction as shown in Figure 10, confocal microscopy
was used as an additional approach to investigate the subcellular
location of IR-sensitive I
B
. For this study cells were grown on
chamber slides and immunocytochemistry performed using an EGFR antibody
to demarcate the PM (green fluorescence) and an antibody to I
B
(red fluorescence). As shown in Figure 11, in control untreated U251 cells
I
B
was distributed throughout the cell. Treatment with TNF-
resulted in the complete loss of I
B
, consistent with the
immunoblot analysis shown in Figure 2A. In contrast, IR
seems to result in the loss of I
B
primarily around the periphery
of the cell. Thus, these data along with the cell fractionation studies
suggest that IR selectively targets I
B
associated with the plasma
membrane.
|
| |
DISCUSSION |
|---|
|
|
|---|
The ability of diverse stimuli such as cytokines, hypoxia, UV
radiation, and ionizing radiation to activate NF-
B suggests that
this transcription factor is susceptible to activation via a number of
signaling pathways (Koong et al., 1994
; Li and Karin, 1998
;
Uehara et al., 1999
; Gao et al., 2001
). Along
these lines, Anderson et al. (1994)
illustrated the
existence of stimuli-specific signaling pathways by showing that
oxidative stress (H2O2)
triggered NF-
B activation in only one of two human T-cell lines,
whereas cytokines and phorbol esters stimulated NF-
B in both cell
lines. Although the specific processes mediating activation by TNF-
have been well defined, the signaling events involved in NF-
B activation after other stimuli have not been fully elucidated. NF-
B
activation by hypoxia involves tyrosine, rather than serine phosphorylation and is accompanied by I
B
degradation (Koong et al., 1994
). In contrast, Imbert et al. (1996)
reported that treatment of Jurkat T cells with pervanadate resulted in
tyrosine phosphorylation of I
B
and activation of NF-
B
independently of I
B
degradation. Finally, UV-C was shown to
activate NF-
B in the absence of an increase in IKK activity (Li and
Karin, 1998
). Defining the individual signaling pathways that lead to
the activation of NF-
B would not only be of fundamental value but
may also provide the basis for approaches that inhibit NF-
B
activation by a specific agent, yet would not affect NF-
B activation
generated by other stimuli.
With respect to IR, it was initially noted that NF-
B activation
occurs in the absence of I
B
degradation, that is, based on the
analysis of whole cell lysates. The ability of IR to activate NF-
B
in the absence of I
B
degradation suggested that IR may, in fact,
activate a signaling pathway similar to that of pervanadate involving
the tyrosine phosphorylation of I
B
(Imbert et al., 1996
). However, we recently showed that exposure of U251 cells to IR
resulted in the serine phosphorylation of I
B
(Russell et
al., 2002
). Furthermore, and more convincingly, data in this report (Figure 4) revealed that proteosome inhibition significantly reduced activation of NF-
B after IR. These results indicated that
I
B
degradation was indeed a critical step in IR-induced NF-
B
activation, but undetectable using standard approaches.
A possible explanation was that IR was affecting a specific, smaller
pool of I
B
. This would be consistent with the relative inefficiency of IR as an activator of NF-
B compared with TNF-
(Li
and Karin, 1998
; Shao et al., 2001
). Whereas the classical paradigm of NF-
B activation defines I
B
as a cytoplasmic
protein (Karin and Ben Neriah, 2000
), several reports have shown that I
B
can localize or interact with subcellular compartments other than the cytoplasm. I
B
has been detected in the nucleus where it
associates with NF-
B dimers and returns them to the cytoplasm as
inactive complexes (Hay et al., 1999
; Rodriguez et
al., 1999
; Sachdev et al., 2000
). In addition, Cuervo
et al. (1998)
demonstrated that in Chinese hamster ovary
cells I
B
could also be found in lysosomes; under conditions of
nutrient deprivation lysosomal I
B
was degraded resulting in the
activation of NF-
B. Finally, I
B
can also exist in the
mitochondria associated with ANT, a mitochondrial ATP transport protein
(Bottero et al., 2001b
). To determine whether IR affected a
subcellular pool of I
B
other than that located in the cytoplasm,
U251 cell lysates were first fractionated into insoluble and soluble
components. These initial studies clearly showed that IR resulted in a
loss of I
B
in the insoluble cell fraction without having any
effect on I
B
in the soluble portion (i.e., the cytoplasmic pool).
This is in contrast to treatment with TNF-
, which degraded I
B
in both fractions. However, as shown in Figure 5, the majority of
I
B
is localized in the soluble cell fraction consistent with
previous studies (Karin and Ben Neriah, 2000
), which explains the
failure to detect I
B
degradation after IR when using the standard
approach of evaluating whole cell lysates. Regarding the other members
of the I
B protein family, whereas I
B
was detected in both the soluble and insoluble fractions, I
B
was only found in the soluble compartment. Furthermore, I
B
was degraded after exposure to TNF-
; I
B
was not affected by treatment with TNF-
or IR.
These variations in location and susceptibility to stimuli may reflect the different roles of the I
B family members in the regulation of
NF-
B activity (Baeuerle and Baltimore, 1996
; Renard et
al., 2000
).
The localization of IR-sensitive I
B
to the insoluble protein
fraction was shown for the U251 and SF539 cells lines, which are both
susceptible to IR-induced NF-
B. Interestingly, in the BXPC-3 cell
line, which does not activate NF-
B in response to IR, I
B
was
only detected in the soluble and not in the insoluble cell fraction.
Although these results were generated from only three cell lines, they
suggest that I
B
localization plays a role in determining the
susceptibility to IR-induced NF-
B activation. However, it should be
noted that in HeLa cells, Li and Karin (1998)
showed that IR-induced
NF-
B activity is accompanied by I
B
degradation in whole cell
extracts, although to a smaller extent than detected after TNF-
treatment. This may reflect cell type specificity or different levels
of I
B
in the insoluble fraction, such that their loss is not
masked by the "dominant" soluble fraction.
Investigations using serial centrifugation narrowed the locale of
IR-sensitive I
B
to the ER and/or PM fractions. Further studies
attempting to obtain enriched ER and PM fractions combined with
confocal microscopy after immunocytochemical analyses suggested that
the IR-susceptible I
B
/NF-
B complex is located at the plasma membrane. This was unexpected given that previous work seemed to
suggest that I
B
found in the nucleus or mitochondria would be of
the most biological significance, i.e., after that found in the
cytoplasm (Hay et al., 1999
; Rodriguez et al.,
1999
; Sachdev et al., 2000
). However, although clearly
detected in these organelles of U251 cells, the I
B
found in the
nuclei and mitochondria, like that in the cytoplasm, was not sensitive
to IR-induced degradation. The membrane association of I
B
is
actually consistent with previous results showing that a single chain
antibody fragment targeted to Ras protein inhibits IR-induced NF-
B
activation in U251 cells and other cell lines (Russell et
al., 2002
). This inhibition only occurred in cells that expressed
an active form of Ras (Russell et al., 2002
). Thus, a
possible scenario is that active Ras proteins are involved in
recruiting I
B
/NF-
B complexes to the cell membrane. It should
be noted that BXPC-3 cells, which do not activate NF-
B after IR and
do not have I
B
in the insoluble fraction, also do not contain
significant levels of activated Ras (Russell et al., 2002
).
The studies presented herein demonstrate that, whereas TNF-
treatment results in degradation of all cellular I
B
, including the dominant pool in the cytoplasm, IR-induced degradation is selective
for I
B
located in the insoluble cell component, putatively at the
PM. One of the critical questions then raised by this study pertains to
the resistance of the cytoplasmic pool of I
B
to IR-induced
degradation. A possible explanation may lie in the multiple effects of
TNF-
. This cytokine interacts with its specific receptors, which
have been mechanistically linked to the signaling pathway regulating
IKK and subsequent I
B
phosphorylation and degradation
(Pimentel-Muinos and Seed, 1999
). However, TNF-
treatment also
generates reactive oxygen species (ROS) (Chandel et al., 2001
; Kohler et al., 2001
) with antioxidant treatment
inhibiting TNF-
-induced NF-
B activation (Legrand-Poels et
al., 1997
). In contrast, IR does not serve as a specific receptor
ligand, but it does generate ROS. Thus, the situation may exist in
which the soluble (cytoplasmic) pool of I
B
is activated via
specific receptor-mediated signaling complexes, but the insoluble pool
of I
B
is activated as a result of ROS generation. Thus, whereas
IR fails to activate the receptor-mediated signaling pathway necessary
for degradation of the soluble pool of I
B
, it does generate ROS
sufficient for activation mediated by the insoluble pool of I
B
.
In contrast, TNF-
activates both pathways and is considerably more
efficient at activating NF-
B. Clearly, additional studies are needed
to define the specific signaling pathways mediating IR-induced NF-
B activation. The data presented herein, however, do illustrate that an
additional level of regulation of NF-
B activation involves subcellular localization.
| |
ACKNOWLEDGMENTS |
|---|
We thank Susan Garfield (Confocal Microscopy Core Facility, Laboratory of Experimental Carcinogenesis, National Cancer Institute) for assistance with the confocal microscopy.
| |
FOOTNOTES |
|---|
Corresponding author. E-mail address:
tofilonp{at}mail.nih.gov.
Article published online ahead of print. Mol. Biol. Cell 10.1091/mbc.E02-05-0252. Article and publication date are at www.molbiolcell.org/cgi/doi/10.1091/mbc.E02-05-0252.
| |
REFERENCES |
|---|
|
|
|---|
B signal transduction pathway.
Proc. Natl. Acad. Sci. USA
91, 11527-11531
B: ten years after.
Cell
87, 13-20[CrossRef][Medline].
B through the IKK complex by the topoisomerase poisons SN38 and doxorubicin: a brake to apoptosis in HeLa human carcinoma cells.
Cancer Res.
61, 7785-7791
B-
, the NF-
B inhibitory subunit, interacts with ANT, the mitochondrial ATP/ADP translocator.
J. Biol. Chem.
276, 21317-21324
B.
J. Clin. Invest
88, 691-695.
cytotoxicity: activation of NF-
B and nuclear translocation.
Exp. Cell Res.
224, 63-71[CrossRef][Medline].
B is a substrate for a selective pathway of lysosomal proteolysis.
Mol. Biol. Cell
9, 1995-2010
B
of nuclear factor-
B in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo.
Cancer Res.
59, 3468-3474
B and AP-1 as regulated by protein kinase C and mitogen-activated protein kinase.
Virology
286, 91-99[CrossRef][Medline].
B transcriptional activation by signal induced proteolysis of I
B
.
Phil. Trans. R. Soc. Lond. B Biol. Sci.
354, 1601-1609[CrossRef][Medline].
B-
activates NF-
B without proteolytic degradation of I
B-
.
Cell
86, 787-798[CrossRef][Medline].
]B activity.
Annu. Rev. Immunol.
18, 621-663[CrossRef]